Tau Phosphorylation—Much More than a Biomarker

Sumihiro Maeda; Lennart Mucke

doi:10.1016/j.neuron.2016.10.011

Tau Phosphorylation—Much More than a Biomarker

Sumihiro Maeda, Lennart Mucke

研究成果: Short survey › 査読

9 被引用数 (Scopus)

抄録

Lasagna-Reeves et al. (2016) demonstrate that preventing the kinase Nuak1 from phosphorylating the microtubule-associated protein tau reduces the level of potentially pathogenic tau species in brain, a novel therapeutic strategy that could help counteract Alzheimer's disease and several other neurological disorders.

本文言語	English
ページ（範囲）	265-267
ページ数	3
ジャーナル	Neuron
巻	92
号	2
DOI	https://doi.org/10.1016/j.neuron.2016.10.011
出版ステータス	Published - 2016 10月 19
外部発表	はい

ASJC Scopus subject areas

神経科学（全般）

文献へのアクセス

10.1016/j.neuron.2016.10.011

他のファイルとリンク

引用スタイル

@article{3ffdd218e4d64581a756af309660ecab,

title = "Tau Phosphorylation—Much More than a Biomarker",

abstract = "Lasagna-Reeves et al. (2016) demonstrate that preventing the kinase Nuak1 from phosphorylating the microtubule-associated protein tau reduces the level of potentially pathogenic tau species in brain, a novel therapeutic strategy that could help counteract Alzheimer's disease and several other neurological disorders.",

author = "Sumihiro Maeda and Lennart Mucke",

note = "Funding Information: L.M. and S.M. are supported by the Tau Consortium. L.M. is a co-inventor on tau-related patents owned by the Gladstone Institutes. L.M. is also the principal investigator of sponsored research collaborations of the Gladstone Institutes with Bristol-Myers Squibb and with Cure Network Dolby Acceleration Partners. Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",

year = "2016",

month = oct,

day = "19",

doi = "10.1016/j.neuron.2016.10.011",

language = "English",

volume = "92",

pages = "265--267",

journal = "Neuron",

issn = "0896-6273",

publisher = "Cell Press",

number = "2",

}

TY - JOUR

T1 - Tau Phosphorylation—Much More than a Biomarker

AU - Maeda, Sumihiro

AU - Mucke, Lennart

N1 - Funding Information: L.M. and S.M. are supported by the Tau Consortium. L.M. is a co-inventor on tau-related patents owned by the Gladstone Institutes. L.M. is also the principal investigator of sponsored research collaborations of the Gladstone Institutes with Bristol-Myers Squibb and with Cure Network Dolby Acceleration Partners. Publisher Copyright: © 2016 Elsevier Inc.

PY - 2016/10/19

Y1 - 2016/10/19

N2 - Lasagna-Reeves et al. (2016) demonstrate that preventing the kinase Nuak1 from phosphorylating the microtubule-associated protein tau reduces the level of potentially pathogenic tau species in brain, a novel therapeutic strategy that could help counteract Alzheimer's disease and several other neurological disorders.

AB - Lasagna-Reeves et al. (2016) demonstrate that preventing the kinase Nuak1 from phosphorylating the microtubule-associated protein tau reduces the level of potentially pathogenic tau species in brain, a novel therapeutic strategy that could help counteract Alzheimer's disease and several other neurological disorders.

UR - http://www.scopus.com/inward/record.url?scp=84992363280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992363280&partnerID=8YFLogxK

U2 - 10.1016/j.neuron.2016.10.011

DO - 10.1016/j.neuron.2016.10.011

M3 - Short survey

C2 - 27764656

AN - SCOPUS:84992363280

SN - 0896-6273

VL - 92

SP - 265

EP - 267

JO - Neuron

JF - Neuron

IS - 2

ER -

Tau Phosphorylation—Much More than a Biomarker

抄録

ASJC Scopus subject areas

文献へのアクセス

他のファイルとリンク

フィンガープリント

引用スタイル